McAlevey, who currently serves as vice president, general counsel and business development leader for GE Healthcare, will succeed Bob Waterman who is retiring September 30 after 24 years with HCA Healthcare.
“Mike is an accomplished lawyer and highly respected leader with deep experiences in large, complex, regulated businesses,” said Sam Hazen, chief executive officer of HCA Healthcare. “We look forward to welcoming him into our organization as part of our senior management team.”
McAlevey has been with GE for 19 years in various legal counsel leadership positions. In his role with GE Healthcare, McAlevey leads a large department of lawyers responsible for legal, compliance and business development for the medical technology provider. McAlevey joined GE in 2003 as chief corporate, securities and governance counsel. In 2011, he was appointed general counsel and business development leader for GE Aviation, and he assumed his current role in 2018.
Before joining GE, McAlevey served as deputy director of the Securities and Exchange Commission’s Division of Corporation Finance. Prior to that, he was a partner with Alston & Bird, LLP from 1990 to 1998 and an adjunct professor of law at the Georgetown University Law Center from 1999 to 2002.
McAlevey has a bachelor’s degree from Washington and Lee University, where he currently serves as chairman of the board of trustees. He received his law degree from the University of Virginia School of Law. Following law school, McAlevey served as a law clerk to the Honorable Emmett R. Cox, United States Eleventh Circuit Court of Appeals.
Waterman is retiring as the longest serving, active general counsel in the Fortune 100, and he will also be the longest tenured general counsel to have ever served HCA Healthcare. He joined the company in 1997 after his time with the San Francisco office of Latham & Watkins, where he was a partner and Chair of the firm’s healthcare group.
“For 24 years, HCA Healthcare has relied on Bob for his thoughtful judgment and keen insights in support of our culture, values and patient care mission,” said Hazen. “He has been a trusted advisor and friend to me and many others during his tenure, and we wish him well in retirement.”
What is Michael R. McAlevey's net worth?
The estimated net worth of Michael R. McAlevey is at least $337,018.20 as of April 29th, 2022. Mr. McAlevey owns 1,110 shares of HCA Healthcare stock worth more than $337,018 as of December 21st. This net worth approximation does not reflect any other investments that Mr. McAlevey may own. Additionally, Mr. McAlevey receives a salary of $2,700,000.00 as SVP at HCA Healthcare. Learn More about Michael R. McAlevey's net worth.
How old is Michael R. McAlevey?
Mr. McAlevey is currently 60 years old. There are 5 older executives and no younger executives at HCA Healthcare. The oldest executive at HCA Healthcare is Dr. Thomas F. Frist Jr., M.D., Founder & Chairman Emeritus, who is 85 years old. Learn More on Michael R. McAlevey's age.
What is Michael R. McAlevey's salary?
As the SVP of HCA Healthcare, Inc., Mr. McAlevey earns $2,700,000.00 per year. There are 3 executives that earn more than Mr. McAlevey. The highest earning executive at HCA Healthcare is Mr. Samuel N. Hazen, CEO & Director, who commands a salary of $7,120,000.00 per year. Learn More on Michael R. McAlevey's salary.
How do I contact Michael R. McAlevey?
Has Michael R. McAlevey been buying or selling shares of HCA Healthcare?
Michael R. McAlevey has not been actively trading shares of HCA Healthcare during the last ninety days. Most recently, on Friday, April 29th, Michael R. Mcalevey bought 1,110 shares of HCA Healthcare stock. The stock was acquired at an average cost of $218.56 per share, with a total value of $242,601.60. Following the completion of the transaction, the senior vice president now directly owns 1,110 shares of the company's stock, valued at $242,601.60. Learn More on Michael R. McAlevey's trading history.
Who are HCA Healthcare's active insiders?
HCA Healthcare's insider roster includes Erol Akdamar (Insider), Jennifer Berres (SVP), Phillip Billington (SVP), Jeffrey Cohen (SVP), Michael Cuffe (Insider), Jane Englebright (SVP), Jon Foster (Insider), Thomas Frist, Jr. (Major Shareholder), Charles Hall (Insider), Samuel Hazen (CEO & Director), Michael McAlevey (SVP), Timothy McManus (Insider), Sandra Morgan (SVP), A. Morre, Jr. (Insider), Sammie Mosier (Senior Vice President and Chief Nurse Executive), P. Paslick (SVP), Jonathan Perlin (CMO), Deborah Reiner (SVP), Wayne Riley (Director), Bill Rutherford (CFO), William Rutherford (Exec. VP & CFO ), Andrea Smith (Director), Joseph Sowell, III (SVP), Kathryn Torres (SVP), Chad Wasserman (SVP), Robert Waterman (SVP), Kathleen Whalen (SVP), and Christopher Wyatt (SVP). Learn More on HCA Healthcare's active insiders.
Are insiders buying or selling shares of HCA Healthcare?
During the last twelve months, insiders at the sold shares 18 times. They sold a total of 51,236 shares worth more than $17,305,720.38. The most recent insider tranaction occured on November, 14th when SVP Phillip G Billington sold 3,897 shares worth more than $1,363,950.00. Insiders at HCA Healthcare own 1.6% of the company.
Learn More about insider trades at HCA Healthcare. Information on this page was last updated on 11/14/2024.
